The U.S. Food and Drug Administration (FDA) is hosting a webinar for device manufacturers and industry to discuss and answer questions about the immediately in effect guidance Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency.

Find out more information and register below.